In our study, the protective effects of melatonin against CI-AKI were confirmed by the decrease of Nox4 expression, ROS production, and lipid peroxidation and the increase in SOD and GSH-Px activities in vivo and in vitro. The gene discussed is SOD1; the disease is acute kidney injury.